The full results of the open label extension (OLE) of the Phase 1b/2a PACIFIC trial investigating bexicaserin for the treatment of patients with Developmental and Epileptic Encephalopathies (DEEs), will be presented for the first time at the International Epilepsy Annual Congress1 DEEs...
Hence then, the article about lundbeck to present new data on bexicaserin at upcoming congress highlighting long term impact on seizure frequency in patients with rare epilepsy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy )
Also on site :
- Creality bringt den SPARKX i8 auf Indiegogo für 289 US-Dollar auf den Markt und bietet damit den schnellsten Druck ohne Spülabfall
- Golden Globe-Nominated Actress Makes Hilarious Confession About Burt Reynolds: ‘Burt Was Absolutely Obsessed with Three Things’
- ‘The Big Bang Theory’ Showrunner Reveals He Also Wasn’t Happy With One of Its Most Controversial Storylines